Franklin Resources Inc Syros Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

  • $313 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.69 - $1.21 $13,323 - $23,365
-19,310 Reduced 30.65%
43,690 $42,000
Q4 2021

Feb 11, 2022
SELL
$3.26 - $4.66 $3,260 - $4,660
-1,000 Reduced 1.56%
63,000 $205,000
Q3 2021

Nov 12, 2021
BUY
$4.08 - $5.66 $261,120 - $362,240
64,000 New
64,000 $286,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email